Preparing for your First Appointment
Living Life to The Fullest
Scleroderma and Comorbidities; Pulmonary Hypertension
Community Impact: A Closer Look at Scleroderma Ontario's 2024 Grant Recipients
Surviving the Cold While Living with Raynaud’s and SSc.
Sanique's #MySclerodermaStory
Spring 2023 Newsletter
Spring 2023 Letters
The Impact of Internet Virality on Scleroderma
Summer Newsletter 2022
Employment Outcomes in Systemic Sclerosis
UPDATED COVID GUIDANCE: MASKS & VACCINES
4th Dose COVID-19 Vaccines
(FR) La Scléromyosite - Une nouvelle frontière (EN) Scleromyositis - A New Frontier
Expanded Eligibility - 3rd Doses of COVID-19 Vaccine - MoH Guidelines